MDCX Medicus Pharma Ltd

$MDCX IMO This stock has big potential. I like this stock . Big price target and few recent developments r attractive. IMO high risk high reward play . I will be holding for long to see if it reach my desired price .

$MDCX Because Gorlin Syndrome is a rare disease with a massive unmet medical need, the FDA cleared a Phase 2b trial (SKNJCT-005) designed to serve as a registrational study. Direct Path to Approval: A registrational or "NDA-enabling" trial means that if the Phase 2b data is strong and meets safety and efficacy goals, Medicus Pharma can use it to apply directly for FDA approval (New Drug Application). This allows them to effectively bypass a standard, lengthy Phase 3 trial

$MDCX I double my position and smacked the ask at .17. It lowered my average a bit and showed some bull horns. Bring it.

$MDCX Damn.. they sure make it hard to be a long when put out two great pieces of News and each time there is no real modest upward movement, during normal trading hours, but I will continue to hold LONG.. has to be worth more than 17 cents.. (Ive seen some Analysts call for 3-4$ s plus I think might been based on some milestones but still)

$MDCX terminated its Standby Equity Purchase Agreement with Yorkville, ending a $15M financing option.

$MDCX is extremely beaten down and technically oversold. The Pfizer and Phase 2 recent catalyst gives this a legitimate fundamental reason for a rebound. Starting a small position here.

$MDCX everybody knew a RS was the only option to comtinue the project , expecially MDCX managment , so why beeing so surprised??? This one will be a huge investment within a coupple of year, BE PATIENT !!! 🚀🚀🚀🚀🚀

$MDCX I have done 15 round trips on this today, and only profited just over 1300. Do not listen to the pumpsers on this, the stock will go nowhere. After a 51 RS, it will be finished, if you're a fast trader and using multiple screens, you'll be OK probably today and tomorrow, flipping this. If not, don't even try, and do not hold overnight.

$MDCX piece of crap. they killed the stock few weeks ago, now RS to kill more. this fucking company is not shareholder friendly

$MDCX focuses SkinJect on Gorlin syndrome patients, concentrating development on this rare BCC indication.

$MDCX could RS or could reach compliance by October 19th …. Don’t bet your house just scoop here and there and hold.

$MDCX nobody buys medical small caps for current setup. They buy because sometimes they have the goods and explode, tell tell is other big companies giving them money

$MDCX I got out because of imminante risk of R/S 1:50 that is already approved.Good luck bulls!

$MDCX Haha the CEO was telling everyone to buy his stock while at his beach house playing golf knowing it's going to reverse split, priceless. Total scumbag move champ. He knew this was coming.

$MDCX what the hack they are trying to do here? Crashed this to Penny in a matter of days!?

$MDCX asian stocks are 100 times better than US stocks. look at thelast week, atleast 6 asian stocks have skyrocketed and then ofcourse they went down 80%+, but atleast they went 300%+

$MDCX if ur still holding ur melted scoops just make sure you have a multiple of 50.. don’t let them sell u out on fractional splits

$MDCX not that huge. And only those who bought at .10 are really profiting they will sell the rip.

$MDCX After the Reverse Split (e.g., MDCX's 50-to-1 Split) • Resetting the Short Ladder: A 50-to-1 reverse split shrinks the share count and spikes the nominal share price (e.g., from ~$0.12 to ~$6.00). This resets the "footprint" of the stock. • Fresh Borrow Room & Renewed Shorting: Low-priced stocks (<$1) often face strict borrowing limits or exchange rules. Once the price is jacked up via a reverse split, short-sellers and toxic lenders get a brand-new high-priced equity base to short all over again as the company continues to burn cash and dilute. • The "Dilution Loop": Post-split, cash-strapped companies often issue more shares to stay afloat, causing the newly consolidated price to start bleeding downward once more—allowing the short/convertible cycle to repeat.

$MDCX Before the Reverse Split • Naked & Covered Shorting: Traders borrow shares (or short them) while the price drifts downward from $2+ down to pennies, buying them back much cheaper to pocket the difference. • Toxic / Convertible Debt & Warrants: Hedge funds often buy discounted convertible notes or preferred shares from struggling biotechs. They short the common stock aggressively to lock in risk-free arbitrage profits as they convert debt into cheap shares. • Momentum & Scalp Trading: Algorithmic and day traders play dead-cat bounces, short-term volatility spikes, and high-frequency order book manipulation even in a long-term downtrend.